100 related articles for article (PubMed ID: 4181094)
1. [Clinical application of PPC for prostatic hypertrophy and female cystopathy].
Nishimura Y; Ikeda T
Hinyokika Kiyo; 1969 Feb; 15(2):127-34. PubMed ID: 4181094
[No Abstract] [Full Text] [Related]
2. [Double blind test of PPC for prostatic hyperplasia].
Shimaya M; Sugiura H
Hinyokika Kiyo; 1970 May; 16(5):231-6. PubMed ID: 4194682
[No Abstract] [Full Text] [Related]
3. [Clinical evaluation of Prosta-caps].
Weiser
Dtsch Med J; 1972 Feb; 23(2):155-6. PubMed ID: 4111749
[No Abstract] [Full Text] [Related]
4. [A gastroprotective nitrofuran in urological practice].
Laudi M; Ferrando U; Fontana G; Sesia G
Minerva Urol; 1975; 27(2):83-90. PubMed ID: 49842
[No Abstract] [Full Text] [Related]
5. [Use of amino acids as a combination in the treatment of prostatic hypertrophy].
Menéndez Fernández H; Castillo Vergara P; Hilario García Marcos J; Romero Gil JR
Arch Esp Urol; 1988 Sep; 41(7):495-9. PubMed ID: 2468315
[No Abstract] [Full Text] [Related]
6. [Clinical effect of PPC for the palliative treatment of benign prostatic hypertrophy].
Ishigami J; Kuroda K
Hinyokika Kiyo; 1969 Jan; 15(1):68-75. PubMed ID: 4180035
[No Abstract] [Full Text] [Related]
7. [Clinical application of "PPC" to prostatic hypertrophy and others].
Sugiura H; Shimaya M
Hinyokika Kiyo; 1969 Jun; 15(6):450-3. PubMed ID: 4185864
[No Abstract] [Full Text] [Related]
8. Use of streptokinase instead of surgical interference for the treatment of urinary clot retention.
Hanna A
Urol Surv; 1979 Aug; 29(4):111-2. PubMed ID: 90421
[TBL] [Abstract][Full Text] [Related]
9. Unexpected insights into pelvic function following phosphodiesterase manipulation--what's next for urology?
McVary KT
Eur Urol; 2006 Dec; 50(6):1153-6. PubMed ID: 17045387
[No Abstract] [Full Text] [Related]
10. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
[No Abstract] [Full Text] [Related]
11. [Some personal comments on the care given to patients with benign prostatic hypertrophy in the primary care environment].
Pellicé i Vilalta C
Arch Esp Urol; 1998; 51(1):1-4. PubMed ID: 9557335
[No Abstract] [Full Text] [Related]
12. [The irritable bladder as a test object for spasmolytics. Experimental and clinical testing of benzilic acid-(N,N-dimethyl-2-hydroxymethylpiperidinium)estermethylsulfate].
von Rütte B
Arzneimittelforschung; 1966 Aug; 16(8):929-35. PubMed ID: 4172009
[No Abstract] [Full Text] [Related]
13. [Clinical experiences in the treatment of prostatic hypertrophy with high doses of progesterone administered rectally].
Marini A; Cavalca GG
Minerva Urol; 1974; 26(3):140-5. PubMed ID: 4138638
[No Abstract] [Full Text] [Related]
14. Deep vein thrombosis associated with distension of the urinary bladder due to benign prostatic hypertrophy--a case report.
Meinardi JR; Kremer J; van der Meer J
Neth J Med; 2004 Apr; 62(4):137-8. PubMed ID: 15255085
[TBL] [Abstract][Full Text] [Related]
15. [Androgen deprivation in benign prostatic hypertrophy].
Tenaglia R; Nicolai M; Di Federico G; Iantorno R; Zezza A; Lombardi G
J Urol (Paris); 1993; 99(6):296-8. PubMed ID: 7516371
[TBL] [Abstract][Full Text] [Related]
16. [Clinical experiences with phyto-therapy of benign prostatic hypertrophy].
Bauer KM
Med Welt; 1980 Aug; 31(34):1211-4. PubMed ID: 6159518
[No Abstract] [Full Text] [Related]
17. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
[No Abstract] [Full Text] [Related]
18. [Urological diseases and salivary gland hormone. (1). Prostatic hypertrophy. (2). Functional failure of the bladder].
Furusawa T; Azuma T; Mishina T; Murakami T
Horumon To Rinsho; 1966 Nov; 14(11):915-7. PubMed ID: 4167004
[No Abstract] [Full Text] [Related]
19. [Treatment of prostatic hypertrophy with depostat].
Nuri M; Hochberg K
Munch Med Wochenschr; 1970 May; 112(22):1057-60. PubMed ID: 4192989
[No Abstract] [Full Text] [Related]
20. [Phenotypic changes in human bladder smooth muscle cell].
Matsumoto S; Hanai T; Kurita T; Akiyama T
Hinyokika Kiyo; 2003 Dec; 49(12):715-9. PubMed ID: 14978953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
